Insights on Cannabinoid Exposure in Substance Use Disorders
This 2026 review on cannabinoid exposure substance use disorders analyzes 97 studies with over 41,000 participants. It finds cannabinoids offer short-term symptom relief but lack durable efficacy for abstinence or relapse prevention. The evidence guides…
Cannabinoids in Substance Use Disorders: What a New Systematic Review Actually Found
Cannabinoids and substance use disorders were the focus of a 2026 systematic review spanning 97 studies and nearly 42,000 participants. The review found cannabinoids more often relieved short-term symptoms like craving and withdrawal than they improved…
Lesser-known cannabis compounds show promise for treating alcohol addiction in rats
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthNeurologyCBNTHCVAddictionAlcohol Why This Matters Clinicians treating patients with alcohol use…
In the Mix: Synthetic Cannabinoid Arrests and Clinical Insights
Synthetic cannabinoid arrests highlight ongoing public health challenges in 2026. These arrests often involve heroin, complicating substance use disorder treatment. Understanding synthetic cannabinoid arrests is crucial for clinicians and law enforcement.
In the Mix: 3 More Articles — May 24, 2026
This article discusses cannabinoid pharmaceutical financial challenges impacting drug development in 2026. It highlights the economic struggles of companies developing cannabinoid therapies. Understanding these challenges is essential for clinicians…
In the Mix: 10 More Articles — May 20, 2026
This article reviews adolescent cannabis use disorder treatment delays and emerging clinical trends in 2026. It highlights the importance of monitoring cannabis mental health impacts in youth. Clinicians should consider regulatory developments affecting…
Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. AgingMental HealthResearchSafetyAnxietyNeurologyPain Why This Matters Clinicians managing erectile dysfunction in older…
Beyond Dopamine: New Research Uncovers Multisystem Brain Networks in Addiction Mechanisms
Recent research highlights multisystem brain networks addiction as key in cannabis use disorder. This approach goes beyond dopamine to include endocannabinoid and stress pathways. Understanding these networks can improve clinical treatment outcomes.
In the Mix: 10 More Articles — May 19, 2026
This update features cannabis clinical updates May 2026 with 10 articles scored below the clinical relevance threshold. Topics include substance use patterns, regulatory developments, and emerging research. These cannabis clinical updates May 2026…
New study reveals distinct differences in how different drugs relate to criminal behavior
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPolicyMental HealthSafetyCannabisCrimeDrugs I apologize – I need to select only from your provided list.…